Gordie Howe continues to improve after stem cell treatment

Former Detroit Red Wingsright-winger Gordie Howe's condition has continued to improve after stem cell treatment in December, Howe's family told Helene St. James of the Detroit Free Press.

Howe, who will turn 87 in March, has severe dementia. He had multiple strokes last summer and a serious one in October, and he was hospitalized in December with a case of dehydration.

Howe's family opted to have the NHL legend, who spent 32 years as a professional hockey player, undergo stem cell treatment in December. The familiy has said that his condition has improved markedly since then.

Canadiens honor Charlie Hebdo victims by playing French anthem

Prior to the treatment, Howe was limited to shuffling his feet while sitting down. He has since regained the ability to kick a ball around and to push a shopping cart. He has gone out in public with family members.

Howe's son Mark, who is currently a pro scout for the Red Wings, said that his father "is doing very well, overall."

Howe spent 25 seasons with the Red Wings from 1946 to 1971. After six years with the Houston Aeros and New England Whalers of the World Hockey Association, Howe returned to the NHL for a final season with the Hartford Whalers, retiring in 1980.

Wild honor J.P. Parise with pregame ceremony, helmet decal

During his season in Hartford, Howe, 51 at the time, scored 15 goals and recorded 26 assists in 80 games.

Devils veteran Patrik Elias notches 1,000th career point

The rest is here:
Gordie Howe continues to improve after stem cell treatment

Howe seeing further gains following stem cell treatment

Gordie Howe suffered a major stroke in October and his condition seemed grim at the end of November when his son, Mark Howe, reported that his father was unable to walk and his speech is very minimal.

He started to see an improvement in his health soon after that though and his family said that Howe took amazing steps forward thanks to stem cell treatment in Mexico.

Roughly a month after that treatment, Howe is continuing to make gains. Hes gone from not being able to walk to pushing a cart at a grocery store, Mark informed the Detroit Free Press. Mr. Hockey has also gone to the mall recently and can kicked a small ball around outside.

(Howe) is doing very well, overall, Mark said.

Howe, 86, was also suffering from back problems and has dementia. He lives with his daughter, Cathy, in Lubbock, Texas.

See original here:
Howe seeing further gains following stem cell treatment

Family's hope as blind tot heads to India for medical treatment

A TODDLER is jetting out to India with his mother and grandmother for a second course of treatment which could give him some eyesight.

Little Connor Wrighton, who is just over 13 months old, is having stem cell therapy at a clinic in New Delhi, following treatment he had in the city in October and November.

Parents Nathan and Lisa Wrighton said they were feeling very positive that the pioneering treatment was going to make a major difference to Connors life.

He was born blind and with a form of cerebral palsy. At just 23 days old, Connor had a shunt fitted to relieve the pressure on his brain by taking away fluid to his stomach.

Doctors at Unistem Biosciences in New Delhi are starting a new phase of treatment for Connor, taking cells from his hips to hopefully regenerate his eyes. The latest course of treatment is expected to last just under two weeks.

Mr Wrighton, formerly of Oxenhope and Silsden and an ex-student of South Craven School in Cross Hills, said the family was very hopeful that the stem cell therapy would make a significant difference to his sons sight.

He added: "We were very impressed with the doctors last time we feel very confident the treatment is going well.

"Connor does seem to have started to react to light and we believe there is some vision there. We always knew it was a bit of a long shot but obviously we want to give him every chance we can. So far we are delighted with Connors progress and feel very positive."

Mum Lisa and her mother, Joyce Stallebrass, are accompanying Connor on the trip this week and staying with him at the hospital, where he is expected to be for 12 or 13 days.

As the therapy is not available on the NHS, the family had to start an appeal to raise the cash to pay for the treatment, and raised about 25,000 in donations from well-wishers in just four months.

Go here to read the rest:
Family's hope as blind tot heads to India for medical treatment

NHL Notebook: Gordie Howes health continutes improving after stem cell treatment – Mon, 12 Jan 2015 PST

The remarkable resurgence of Detroit Red Wings legend Gordie Howe continues, as he has gone from wheelchair bound to pushing a shoppingcart.

Son Mark Howe, who was at Saturdays game between the Wings and Washington Capitals in his role as a Wings pro scout, told the Detroit Free Press that Gordie Howe is doing very well,overall.

Gordie Howe, who turns 87 in March, has severe dementia and has suffered a series of strokes since last summer, including a serious one in October. He was rushed to hospital in early December with what was feared to be another

You have viewed 20 free articles or blogs allowed within a 30-day period. FREE registration is now required for uninterrupted access.

S-R Media, The Spokesman-Review and Spokesman.com are happy to assist you. Contact Customer Service by email or call 800-338-8801

The remarkable resurgence of Detroit Red Wings legend Gordie Howe continues, as he has gone from wheelchair bound to pushing a shoppingcart.

Son Mark Howe, who was at Saturdays game between the Wings and Washington Capitals in his role as a Wings pro scout, told the Detroit Free Press that Gordie Howe is doing very well,overall.

Gordie Howe, who turns 87 in March, has severe dementia and has suffered a series of strokes since last summer, including a serious one in October. He was rushed to hospital in early December with what was feared to be another stroke, but turned out to bedehydration.

The family sons Mark, Marty, Murray and daughter Cathy, the latter of whom Gordie Howe resides with in Lubbock, Texas opted to have Gordie Howe undergo stem cell treatment in mid-December. Since then, their fathers quality of life has improved to the point he goes out in public accompanied by familymembers.

Before the treatment, Mark Howe said, his fathers mobility was limited to shuffling his feet forward while sitting in a wheelchair. Now hes able to kick a small ball around outside. And within the past few days, dad was pushing a cart at a grocery store, and hes gone to the mall, Mark Howesaid.

Read the original here:
NHL Notebook: Gordie Howes health continutes improving after stem cell treatment - Mon, 12 Jan 2015 PST

CSU research on horse injuries, stem-cell recovery, may help humans

Doctors, nurses and anesthesiologist's care for a horse that will be receiving stem cells to help repair a meniscal tear in the stifle at the CSU Veterinary Teaching Hospital in Fort Collins. (Joe Amon, The Denver Post)

Stem-cell research by Colorado State University staffers using bone marrow from horses to heal joint injuries on the same animal is making strides, and researchers have great hope that the project will lead to human medical applications.

A team with CSU's Equine Orthopaedic Research Center reports that adding stem-cell therapy to traditional arthroscopic surgery on horses has significantly increased success rates.

Horses that had follow-up, stem-cell treatment were twice as likely to return to normal activity as those that did not, said David Frisbie, an associate professor of equine surgery with CSU and part of the research team.

"We've doubled it, conservatively," in treating cartilage damage in the knee, Frisbie said.

The team had results of its work published last year in the journal Veterinary Surgery.

Some lesions in the meniscus of horses that could not be treated by surgery have been successfully mended using stem cells alone.

"Western performance horses, reining and cutting horses, and barrel horses are very prone to meniscal injuries," Frisbie said.

Beyond meniscus damage, researchers also have focused on tendon lesions in the lower leg, which typically strike race horses.

Horses that suffered a tendon lesion had about a 66 percent chance of reinjury after surgery. Add stem-cell treatment and the reinjury rate drops to 21 percent, Frisbie said.

Follow this link:
CSU research on horse injuries, stem-cell recovery, may help humans

Gamida Cell treatment granted orphan drug status

Stem cell therapy developer Gamida Cell has been awarded orphan drug status by the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) for leukemia treatment NiCord. The investigational drug treats acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Hodgkin lymphoma and myelodysplastic syndrome (MDS). Gamida Cell intends to file for NiCord orphan drug status with the EMA for other indications as well.

Gamida Cell president and CEO Dr. Yael Margolin said, "Receipt of orphan drug status for NiCord in the US and Europe advances Gamida Cell's commercialization plans a major step further, as both afford significant advantages. We very much appreciate the positive feedback and support of the FDA and EMA and look forward to continuing what has been a very positive dialogue with these important agencies."

The FDA and EMA grant an orphan drug designation to promote the development of products that demonstrate promise for the treatment of rare diseases or conditions. Orphan drug designation provides for various regulatory and economic benefits, including seven years of market exclusivity in the US and 10 years in the EU.

NiCord is derived from a single cord blood unit, which has been expanded in culture and enriched with stem cells using Gamida Cell's proprietary NAM technology. It is currently being tested in a Phase I/II study as an investigational therapeutic treatment for hematological malignancies such as leukemia and lymphoma. In this study, NiCord is being used as the sole stem cell source.

Published by Globes [online], Israel business news - http://www.globes-online.com - on January 6, 2015

See the rest here:
Gamida Cell treatment granted orphan drug status

Brainstorm Stem-Cell Therapy Continues to Show Treatment Effect in ALS Patients

By: Adam Feuerstein | 01/05/15 - 10:52 AM EST

Once injected, the NurOwn stem cells bathe the damaged neurons of ALS patients with secretions of nerve growth factors. Brainstorm has a home run on its hands if NurOwn can be shown to slow or halt the progressive destruction of neurons, and if that disease-modifying effect translates into improved muscle function for ALS patients. Monday's update comes from a Phase IIa trial in which 14 ALS patientswere followed for the three months without treatment. At month four, each patient wastransplanted with their own personalized NurOwn therapy and then assessed every month for six months. Brainstorm evaluated NurOwn's impact on ALS disease progression using the ALSFRS score, a commonly used assessment of treatment response and muscle function in ALS patients. Lung function, another commonly used measure of efficacy in ALS clinical trials, was also measured.

Twelve ALS patients were evaluable for response. Of these, 11 patientsshowed aslowing of ALS disease progression at six months compared to baseline, measured either by improved ALSFRS or lung function scores, Brainstorm said. Two other patients enrolled in the study died. Administration of the NurOwn therapy was well tolerated by patients, the company said.

The final Phase IIa data announced Monday were a small improvement over interim results from the same study presented last June. Further, detailed data from the study will be presented at a medical meeting later this year. For perspective purposes, it's important to note that this phase IIa study enrolled a relatively small number of ALS patients and was conducted at a single hospital in Israel. This doesn't necessarily discredit the positive results, but conclusions about NurOwn's ultimate benefit as an ALS therapy can't be drawnuntil data from larger studies are gathered.

Brainstorm is conducting another, larger Phase II study in the U.S., enrolling 48 ALS patients who will be randomized 3:1 to receive a single NurOwn treatment in the muscle and spine, or a placebo treatment. The study is being conducted at two hospitals in Massachusetts, UMass Medical Center and Massachusetts General, and the Minnesota-based Mayo Clinic. The study's primary endpoint is the safety and tolerability of NurOwn, but investigators will also assess ALS patients for efficacy using measures of ALS disease activity and muscle function. The first patient was enrolled into the Phase II study last June and Brainstorm expects results to be ready in the first half of 2016.

The company is also in the planning stages for another Phase II study in which ALS patients will be treated with multiple doses of NurOwn. Must Read: 11 Best Small-Cap Technology Stocks That Could Hit It Big in 2015

Here is the original post:
Brainstorm Stem-Cell Therapy Continues to Show Treatment Effect in ALS Patients

Restore and Regenerate

Some people say that osteoarthritis, cartilage degradation, and chronic joint pains degenerative diseases associated with agingare conditions with no cure, but Dr. Charlie Poblete and Dr. Jae Pak say otherwise.

It is a new era of medicine, opens Dr. Jae Pak, one of Koreas premier orthopedic stem cell surgeons and a visiting expert consultant of the Stem Care Orthopedics Department under Aivee Institute (AI). He was recently in the country to shed light on stem cell therapy and how it offers more accessible treament options for patients suffering from degenerative orthopedic conditions.

Dr. Pak was joined by Dr. Charlie Poblete, one of the countrys leading orthopedic surgeon who has a special interest on regenerative medicine and stem cells. Incidentally, Dr. Poblete is the head of the Stem Care Orthopedic Department of AI. Stem cells are not really part of alternative medicine. Its part of a modern medicine because we are talking about the biochemistry that goes on in the body with stem cell treatment, Dr. Charlie relates while adding, the good thing about medicine nowadays is its starting to look at the molecular aspect of the body, the molecular and cellular side of medicine.

Over the years, stem cell therapy has been touted as one procedure that can heal multitude of bone, cartilage, and joint ailments. Stem cells are the bodys natural healing cells. They are recruited by chemical signals emitted by damaged tissues to repair and regenerate the damaged cells. Stem cells derived from an individuals tissues may well be the next major development in medicine. In the right environment, these stem cells can change into bone, cartilage, muscle, fat, collagen, neural tissue, blood vessels, and even some organs. Stem cells may also effect healing by secreting special chemical messengers that repair damaged tissue.

There are many clinical conditions that benefits from stem cell therapy: heart attack patients have shown quicker healing period, improved condition for patients with multiple sclerosis, muscular dystrophy, Parkinsons disease, ALS, and stroke. Stem cells may also be effective in the treatment of macular degeneration, Crohns disease, and numerous pulmonary conditions. Also, stem cells are now used for patients with kidney failure and in the treatment of critical limb ischemia.

Stem Cell therapy is a simple procedure. Fat is aspirated from the tummy or the thighs, and then we separate the stem cells from them. It is then activated and injected into joints to restore and regenerate, explains Dr. Jae.

Stem Care by The Aivee Group is the countrys pioneer in advanced Autologous Stem Cell Therapy with an esteemed orthopedic team of doctors and surgeons regarded with international qualifications. The institute, with its CEO and medical director Dr. Z. Teo, together with his wife dermatologist Dr. Aivee Teo, now features a stronger multifaceted protocol in treating orthopedic ailments with a faster rate of positive patient response. They are also adept in complimentary therapies to further intensify the restorative powers of stem cells through the effective use of Growth Factors, Shockwave, Radio Frequency, and Electro Magnetic Therapies. 4033245, 4031982, 09209665613, 09175210222. http://www.stemcareinstitute.com

View post:
Restore and Regenerate

Stem cell treatment for Multiple Sclerosis – Case study – Video

Stem cell treatment for Multiple Sclerosis - Case study
Mr. Scott recover after his suffer from MS for over 10 years. Puhua International Hospital provide stem cell treatment for neurological and neurosurgical disorders. http://www.puhuachina.com.

By: Puhua Hospital

Read more from the original source:
Stem cell treatment for Multiple Sclerosis - Case study - Video

The Irvine Stem Cell Treatment Center Announces Adult Stem Cell Public Seminars in Orange County, California

Seal Beach, Laguna Hills, and Lake Forest, California (PRWEB) January 05, 2015

The Irvine Stem Cell Treatment Center announces a series of free public seminars on the use of adult stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief.

The seminars will be held on Sunday, January 11, 2015, at 2:30pm and 4:30pm at Marie Callenders Grill, 12489 Seal Beach Blvd., Seal Beach, CA 90740; Tuesday, January 13, 2015, at 2:00pm and 4:00pm at Pollys Pies, 23701 Moulton Parkway, Laguna Hills, CA 92653; Friday, January 16, 2015, at 1:30pm and 3:30pm at Marie Callenders Grill, 12489 Seal Beach Blvd., Seal Beach, CA 90740; Saturday, January 17, 2015, at 2:30pm and 4:30pm at Dennys Restaurant, 23515 El Toro Road, Lake Forest, CA 92630. Please RSVP at (949) 679-3889.

The Irvine Stem Cell Treatment Center, along with sister affiliates, the Miami Stem Cell Treatment Center and the Manhattan Regenerative Medicine Medical Group, abide by investigational protocols using adult adipose derived stem cells (ADSCs) which can be deployed to improve patients quality of life for a number of chronic, degenerative and inflammatory conditions and diseases. ADSCs are taken from the patients own adipose (fat) tissue (found within a cellular mixture called stromal vascular fraction (SVF)). ADSCs are exceptionally abundant in adipose tissue. The adipose tissue is obtained from the patient during a 15 minute mini-liposuction performed under local anesthesia in the doctors office. SVF is a protein-rich solution containing mononuclear cell lines (predominantly adult autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important Growth Factors that facilitate the stem cell process and promote their activity.

ADSCs are the body's natural healing cells - they are recruited by chemical signals emitted by damaged tissues to repair and regenerate the bodys injured cells. The Irvine Stem Cell Treatment Center only uses Adult Autologous Stem Cells from a persons own fat No embryonic stem cells are used. Current areas of study include: Emphysema, COPD, Asthma, Heart Failure, Parkinsons Disease, Stroke, Multiple Sclerosis, Lupus, Rheumatoid Arthritis, Crohns Disease, and degenerative orthopedic joint conditions. For more information, or if someone thinks they may be a candidate for one of the adult stem cell protocols offered by the Irvine Stem Cell Treatment Center, they may contact Dr. Gionis directly at (949) 679-3889, or see a complete list of the Centers study areas at: http://www.IrvineStemCellsUSA.com.

About the Irvine Stem Cell Treatment Center: The Irvine Stem Cell Treatment Center, along with sister affiliates, the Miami Stem Cell Treatment Center and the Manhattan Regenerative Medicine Medical Group, is an affiliate of the Cell Surgical Network (CSN); we are located in Irvine and Westlake, California. We provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment. We utilize a fat transfer surgical technology to isolate and implant the patients own stem cells from a small quantity of fat harvested by a mini-liposuction on the same day. The investigational protocols utilized by the Irvine Stem Cell Treatment Center have been reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Health, Office of Human Research Protection; and the study is registered with Clinicaltrials.gov, a service of the U.S. National Institutes of Health (NIH). For more information, visit our websites: http://www.IrvineStemCellsUSA.com, http://www.MiamiStemCellsUSA.com or http://www.NYStemCellsUSA.com.

See original here:
The Irvine Stem Cell Treatment Center Announces Adult Stem Cell Public Seminars in Orange County, California